• Tue, December 12, 2023
Jack Allen Maintained (BLUE) at Buy with Decreased Target to $7 on, Dec 12th, 2023
Jack Allen of Baird, Maintained "bluebird bio, Inc." (BLUE) at Buy with Decreased Target from $10 to $7 on, Dec 12th, 2023.
Jack has made no other calls on BLUE in the last 4 months.
There are 5 other peers that have a rating on BLUE. Out of the 5 peers that are also analyzing BLUE, 2 agree with Jack's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jeffrey Hung of "Morgan Stanley" Upgraded from Sell to Hold and Increased Target to $7 on, Friday, December 8th, 2023
- Eric Schmidt of "Cantor Fitzgerald" Initiated at Hold on, Tuesday, October 17th, 2023
These are the ratings of the 3 analyists that currently disagree with Jack
- Jason Gerberry of "B of A Securities" Maintained at Strong Buy with Increased Target to $12 on, Monday, December 11th, 2023
- Dane Leone of "Raymond James" Maintained at Buy with Increased Target to $13 on, Wednesday, November 8th, 2023
- Morten Herholdt of "HSBC" Initiated at Strong Buy and Held Target at $4.21 on, Wednesday, September 6th, 2023
Like: 👍
